Programmable methylation engineering: Design principles from alkaloid biosynthesis.

Area of Science:

• Synthetic Biology
• Biotechnology
• Metabolic Engineering

Background:

• Methyltransferases (MTs) are crucial enzymes in alkaloid biosynthesis, influencing scaffold diversification, bioactivity, and physicochemical properties through methylation.
• Current applications of MTs in methyltransferase-tailored alkaloid biosynthesis (MTAB) are limited by challenges such as narrow catalytic plasticity, poor expression, instability, and cofactor imbalance.

Purpose of the Study:

• To provide a design-oriented synthesis of recent advancements in MTAB.
• To highlight key principles for programmable methylation across enzyme, cofactor, and system levels for rational pathway design.

Main Methods:

• Review of natural diversity mining and structure-guided engineering to expand MT catalytic plasticity.
• Strategies for enhancing MT activity and robustness, including expression optimization, structural stabilization, and host adaptation.
• Integrated engineering of the S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) cycle for sustained methylation flux and metabolic control.

Main Results:

• Programmable methylation framework established through enzyme-level engineering, cofactor-level optimization, and system-level metabolic control.
• Demonstrated methods for expanding catalytic plasticity, enhancing enzyme activity, and stabilizing MTs.
• Integrated approaches for optimizing SAM supply, SAH degradation, and metabolic flux balance to mitigate cytotoxicity and improve pathway performance.

Conclusions:

• Recent advances provide a unifying framework for rational design of MT-driven pathways.
• Programmable methylation enables robust and scalable biosynthesis of complex alkaloids and other methylated high-value chemicals.
• Engineering efforts focus on enzyme plasticity, cofactor homeostasis, and dynamic metabolic regulation for optimized production.